Treatment-free remission in patients with chronic myeloid leukemia

dc.contributor.advisorBatár, Péter
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Belgyógyászati Intézet::Haematológiai Tanszékhu_HU
dc.contributor.authorOkoh, Nelson
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentReményi, Gyula
dc.contributor.opponentBodor, Miklós
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Belgyógyászati Intézet::Haematológiai Tanszékhu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Belgyógyászati Intézethu_HU
dc.date.accessioned2021-06-17T10:39:14Z
dc.date.available2021-06-17T10:39:14Z
dc.date.created2020-07-06
dc.description.abstractChronic myeloid leukemia is a disease that affects about 1.9 in every 100 000 people annually and represents 15% of all new cases of leukemia in the West. Survival rates in CML have dramatically increased since the advent of TKIs. The idea of treatment-free remission has drawn extensive research due to the discovery that full reduction can be attained in some CML patients. Withdrawal of TKI treatment on certain patients with deep molecular response has yielded full remission, hence the concept 'treatment-free remission'.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent42hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/311249
dc.language.isoenhu_HU
dc.subjectChronic myeloid leukemiahu_HU
dc.subjectImatinibhu_HU
dc.subjectTyrosine Kinase Inhibitorhu_HU
dc.subjectTreatment-free remissionhu_HU
dc.subjectRelapsehu_HU
dc.subjectRemissionhu_HU
dc.subjectDasatinibhu_HU
dc.subjectDeep Molecular Responsehu_HU
dc.subjectReverse Transcriptase PCRhu_HU
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.subject.dspaceDEENK Témalista::Orvostudomány::Belgyógyászathu_HU
dc.titleTreatment-free remission in patients with chronic myeloid leukemiahu_HU
Fájlok